Redpin Therapeutics
Latest round
- Series A
Last raised
- Mar 2020
Total raised
- $16M
Investors
- 5
About Redpin Therapeutics
Redpin Therapeutics, Inc. specializes in developing innovative gene therapies aimed at addressing chronic diseases.Founded in 2017 in New York, US, Redpin Therapeutics, Inc. focuses on gene therapy development. The company was recently acquired on November 16, 2022, by a consortium including Patient Square Capital and others, which enhances its strategic capabilities. Elma Hawkins serves as CEO.Redpin Therapeutics, Inc. offers a range of gene therapies designed to tackle chronic diseases. These therapies aim to provide innovative solutions that enhance the quality of life for patients.The company generates revenue primarily through partnerships and collaborations in the biotech sector, emphasizing a Business-to-Business (B2B) structure that promotes sustainable growth.Redpin Therapeutics, Inc. plans to integrate its platform and pipeline into Kriya's gene therapy engine following its recent acquisition. This strategic move aims to enhance the development of gene therapies that address diseases affecting millions globally. The company is focused on expanding its product offerings and is exploring new markets, particularly in North America and Europe, to broaden its reach.
Who invested in Redpin Therapeutics
5 investors across 2 rounds
See all investors in Redpin Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Redpin Therapeutics
Who invested in Redpin Therapeutics?
Redpin Therapeutics has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Redpin Therapeutics raised?
Redpin Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Redpin Therapeutics last raise money?
Redpin Therapeutics's most recent round on record is a Series A, in Mar 2020.
What does Redpin Therapeutics do?
Redpin Therapeutics is a biotechnology company.
Where is Redpin Therapeutics headquartered?
Redpin Therapeutics is headquartered in New York, US.
Which VCs invest in companies like Redpin Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Redpin Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Redpin Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.